Summary
31 / 100 · Bulios Score
What speaks for it
- It earns 898 CAD a year on every 100 CAD of invested capital.
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 13% a year over the last 3 years.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (CAD)
Diluted EPS (CAD)
Revenue fell by 6.7% a year over 5 years. Over the last 3 years it fell by 13% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $9.74M.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2022By product
- Other sales and services 100%
By region
- Vietnam 45%
- Mexico 23%
- Brazil 10%
- Netherlands 7.0%
- India 5.7%
- Other 8.7%
Other sales and services brings in 100% of revenue.
Segments in detail